Heron Therapeuti

Quarterly Financials

Values in thousands 2024-12-31 2024-09-30 2024-06-30 2024-03-31
Revenue
$40,781
$42,268
$36,024
$34,670
Gross Profit
30,553
23,352
25,506
26,226
EBITDA
8,734
-4,458
-5,804
-4,109
EBIT
8,153
-6,445
-4,798
Net Income
3,663
-4,848
-9,235
-3,160
Net Change In Cash
40,781
42,268
36,024
34,670
Free Cash Flow
-12,418
2,940
-5,241
-9,516
Cash
25,802
25,741
18,386
20,450
Basic Shares
153,151
152,830
152,305
151,199

Annual Financials

Values in thousands 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Revenue
$144,285
$127,044
$107,672
$86,346
Gross Profit
105,637
61,939
52,798
40,325
EBITDA
-5,056
-103,792
-171,769
-214,807
EBIT
-7,548
-106,691
-174,658
-217,828
Net Income
-13,580
-110,559
-134,516
-217,662
Net Change In Cash
144,285
127,044
107,672
86,346
Cost of Revenue
-14,597
Free Cash Flow
-24,235
-60,334
-148,737
-206,376
Cash
25,802
28,677
15,364
90,541
Basic Shares
152,449
138,135
108,876
98,471

Earnings Calls

Quarter EPS
2024-12-31
$0.02
2024-09-30
-$0.03
2024-06-30
-$0.06
2024-03-31
-$0.02